Home
>
US Stocks
>
Agenus Inc
Agenus Inc
AGEN

Agenus Inc

$5.3215.96%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.55
Today Low/High
5.28 / 5.56
52 Week Low/High
$2.5 / $6.18
P/E ratio
-6.0771
Market Cap
$1.37B

Company Details

Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA.
Organisation
Agenus Inc
Headquaters
Lexington, Massachusetts, US
Employees
359
Industry
Health Technology
CEO
Garo Armen

Discover more

Frequently Asked Questions

What is Agenus Inc share price today

Can Indians buy Agenus Inc shares?

How can I buy Agenus Inc shares from India?

Can Fractional shares of Agenus Inc be purchased?

What are the documents required to start investing in Agenus Inc stocks?

We are a SEBI registered investement advisor